159 related articles for article (PubMed ID: 8889038)
21. The pharmacokinetics of vedaprofen and its enantiomers in dogs after single and multiple dosing.
Hoeijmakers M; Coert A; Helden H; Horspool LJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):305-12. PubMed ID: 15953205
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the correlation between in vivo and in vitro release. Effect of the force of contraction and food on drug release.
Aoki S; Ando H; Ishii M; Ida K; Watanabe S; Ozawa H
Biol Pharm Bull; 1994 Feb; 17(2):291-5. PubMed ID: 8205129
[TBL] [Abstract][Full Text] [Related]
23. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
[TBL] [Abstract][Full Text] [Related]
24. Preparation of controlled release granules of TA-5707F using enteric polymers and ethylcellulose, and their in vivo evaluation.
Yamakita H; Matsukawa Y; Maejima T; Osawa T
Biol Pharm Bull; 1996 Jan; 19(1):106-13. PubMed ID: 8820921
[TBL] [Abstract][Full Text] [Related]
25. [Dissolution properties and bioavailability of ground mixture of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]-pyridine-7-acetate with various pharmaceutical ingredients].
Yamada I; Kawata M; Shibata T; Ogawa K; Yokobe T
Yakugaku Zasshi; 1989 Dec; 109(12):932-7. PubMed ID: 2630636
[TBL] [Abstract][Full Text] [Related]
26. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic evaluations of novel oral morphine sustained release granules.
Nakamura K; Nara E; Fuse T; Akiyama Y
Biol Pharm Bull; 2007 Aug; 30(8):1456-60. PubMed ID: 17666803
[TBL] [Abstract][Full Text] [Related]
28. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
29. Preparation of controlled release tablets of TA-5707F with wax matrix type and their in vivo evaluation in beagle dogs.
Yamakita H; Maejima T; Osawa T
Biol Pharm Bull; 1995 Jul; 18(7):984-9. PubMed ID: 7581255
[TBL] [Abstract][Full Text] [Related]
30. Absorption of diltiazem in beagle dog from pulsatile release tablet.
Ishino R; Yoshino H; Hirakawa Y; Noda K
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3094-6. PubMed ID: 1477926
[TBL] [Abstract][Full Text] [Related]
31. Effect of decrease in both postprandial blood glucose (PBG) and fasting blood glucose (FBG) levels in normal beagle dogs with nateglinide enteric coated granules and immediate release tablets.
Makino C; Ninomiya N; Sakai H; Orita H; Okano A; Yabuki A
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):409-14. PubMed ID: 16595936
[TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
[TBL] [Abstract][Full Text] [Related]
33. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release.
Zou H; Jiang X; Kong L; Gao S
J Pharm Sci; 2008 Jan; 97(1):263-73. PubMed ID: 17803198
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
[TBL] [Abstract][Full Text] [Related]
35. Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals.
Arima N; Kato Y
J Pharmacobiodyn; 1990 Dec; 13(12):739-44. PubMed ID: 2098547
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
Fukui A; Fujii R; Yonezawa Y; Sunada H
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
[TBL] [Abstract][Full Text] [Related]
37. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
38. Buoyant sustained release granules based on chitosan.
Inouye K; Machida Y; Sannan T; Nagai T
Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
